ライフサイエンスコーパス: neonatal sepsis

1 ing efforts designed to reduce the burden of neonatal sepsis.

2 neumoniae, two pathogens commonly related to neonatal sepsis.

3 specially in the setting of culture-negative neonatal sepsis.

4 nces in the incidence of chorioamnionitis or neonatal sepsis.

5 ality and its mechanism in a murine model of neonatal sepsis.

6 r immune-modulating adjunctive therapies for neonatal sepsis.

7 The primary outcome was the incidence of neonatal sepsis.

8 coccus, the leading pathogens of early-onset neonatal sepsis.

9 e agent influence the clinical expression of neonatal sepsis.

10 neonates can be used to augment survival to neonatal sepsis.

11 is known about the role of MyD88 or TRIF in neonatal sepsis.

12 often shares similar clinical features with neonatal sepsis.

13 c, prognostic and therapeutic strategies for neonatal sepsis.

14 vent a significant proportion of early-onset neonatal sepsis.

15 of their potential to impact mortality from neonatal sepsis.

16 cent literature on novel diagnostic tests in neonatal sepsis.

17 a critical role for CXCL10 signaling during neonatal sepsis.

18 the incidence and mortality associated with neonatal sepsis.

19 noglobulin and colony-stimulating factors in neonatal sepsis.

20 itis and delivered neonates with early-onset neonatal sepsis.

21 ly reduce both the incidence and severity of neonatal sepsis.

22 s pneumoniae is a rarely recognized cause of neonatal sepsis.

23 tiae (GBS) is the leading cause worldwide of neonatal sepsis.

24 r ankle, two had Blount disease, and one had neonatal sepsis.

25 ty contributes to increased mortality during neonatal sepsis.

26 reterm delivery, and the neonate is prone to neonatal sepsis and death.

27 reduced IL-18-potentiated mortality to both neonatal sepsis and endotoxemia.

28 val rates from serious infections, including neonatal sepsis and health-care-associated infections, a

29 richia coli K1 is the leading cause of human neonatal sepsis and meningitis and is important in other

30 Streptococcus (GBS) is the foremost cause of neonatal sepsis and meningitis in the United States.

31 Nevertheless, it can cause severe neonatal sepsis and meningitis often clinically indistin

32 oup B streptococci (GBS), a leading cause of neonatal sepsis and meningitis, are transferred to neona

33 B Streptococcus [GBS]) is a leading cause of neonatal sepsis and meningitis, peripartum infections in

34 Key features of Escherichia coli K1-mediated neonatal sepsis and meningitis, such as a strong age dep

35 up B Streptococcus (GBS) is a major cause of neonatal sepsis and meningitis.

36 nia, and group B Streptococcus, which causes neonatal sepsis and meningitis.

37 ates during childbirth is a leading cause of neonatal sepsis and meningitis.

38 up B Streptococcus (GBS) is a major cause of neonatal sepsis and meningitis.

39 p B Streptococcus (GBS) is a common cause of neonatal sepsis and meningitis.

40 tococcus (GBS) is the leading cause of human neonatal sepsis and meningitis.

41 B streptococci (GBS) are a leading cause of neonatal sepsis and meningitis.

42 is 89% and 83% for cut-offs of 10ng/mL (for neonatal sepsis and pelvic inflammatory disease) and 30n

43 ognized effector of IL-18-mediated injury in neonatal sepsis and that disruption of the deleterious a

44 dhood illnesses (eg, pneumonia, malaria, and neonatal sepsis) and delivery of preventive intervention

45 s (GBS) results in 12,000 to 15,000 cases of neonatal sepsis annually in the United States.

46 is one of the most common organisms causing neonatal sepsis as well as serious infections in adults.

47 Precise estimates of neonatal sepsis burden vary by setting.

48 or to chorioamnionitis, fetal infection, and neonatal sepsis, but the understanding of specific facto

49 cs of women with preterm IAI and the risk of neonatal sepsis deserve further study.

50 Although neonatal sepsis due to the peripartum transmission of S.

51 tra-amniotic infection (IAI) and early-onset neonatal sepsis (EONS).

52 and pathways of transmission for early-onset neonatal sepsis globally.

53 ctoferrin in the prevention and treatment of neonatal sepsis have been reviewed.

54 adjuvant for the prevention and treatment of neonatal sepsis holds promise.

55 B Streptococcus (GBS) is a leading cause of neonatal sepsis in developed countries.

56 findings suggest that a large proportion of neonatal sepsis in developing countries could be effecti

57 reptococcus (GBS) remains a leading cause of neonatal sepsis in high-income contexts, despite decline

58 w of technologies for the rapid diagnosis of neonatal sepsis includes new adaptations of time-honored

59 Considering the fact that the incidence of neonatal sepsis increases dramatically with decreasing g

60 e slowest progress were congenital, preterm, neonatal sepsis, injury, and other causes.

61 omes (perinatal death, chronic lung disease, neonatal sepsis, intraventricular hemorrhage >grade 2, p

62 Neonatal sepsis is a significant cause of morbidity and

63 tment with a Toll-like receptor 4 agonist to neonatal sepsis is dependent on an endogenous CXCL10 res

64 Neonatal sepsis is the cause of substantial morbidity an

65 de range of other acute illnesses, including neonatal sepsis-like disease, acute flaccid paralysis, a

66 encephalitis, acute respiratory illness, and neonatal sepsis-like disease.

67 up B Streptococcus (GBS) is a major cause of neonatal sepsis, meningitis in early infancy, postpartum

68 agonists may be a useful strategy to prevent neonatal sepsis mortality.

69 Neonatal sepsis occurred in 23 (2%) of 923 neonates whos

70 veillance hospitals with physician-diagnosed neonatal sepsis or ALRTI were enrolled.

71 er, S. bovis is capable of causing fulminant neonatal sepsis or meningitis that is indistinguishable

72 bor, intraamniotic or postpartum infections, neonatal sepsis, or admission of the infant to the neona

73 ect C-reactive protein (CRP)-a biomarker for neonatal sepsis, pelvic inflammatory disease, and inflam

74 most significant bacterial pathogen causing neonatal sepsis, pneumonia and meningitis in the USA des

75 most significant bacterial pathogen causing neonatal sepsis, pneumonia, and meningitis in the United

76 eptococci (GBS) are the most common cause of neonatal sepsis, pneumonia, and meningitis.

77 Successful management of neonatal sepsis requires early diagnosis, appropriate an

78 lk samples from the mother of an infant with neonatal sepsis; sequencing of the enterovirus isolate i

79 l as other extracellular bacterial agents of neonatal sepsis (staphylococci and enterococci) induced

80 common causes such as maternal hypertension, neonatal sepsis, twin-twin transfusion, alloimmunization

81 Surveillance for suspected neonatal sepsis was conducted in Mirzapur, Bangladesh, f

82 ms were the predominant cause of early-onset neonatal sepsis, with a high prevalence of extended-spec